Protara Therapeutics Files Q1 2025 10-Q Report
Ticker: TARA · Form: 10-Q · Filed: May 8, 2025 · CIK: 1359931
| Field | Detail |
|---|---|
| Company | Protara Therapeutics, Inc. (TARA) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, biotech
TL;DR
Protara Therapeutics filed its Q1 2025 10-Q. All systems go.
AI Summary
Protara Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, formerly known as ArTara Therapeutics, Inc. and PROTEON THERAPEUTICS INC, is focused on biological products. Its principal executive offices are located at 345 Park Avenue South, 3rd Floor, New York, NY.
Why It Matters
This filing provides investors with an update on Protara Therapeutics' financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Players & Entities
- Protara Therapeutics, Inc. (company) — Registrant
- ArTara Therapeutics, Inc. (company) — Former company name
- PROTEON THERAPEUTICS INC (company) — Former company name
- March 31, 2025 (date) — Quarterly period end date
- 345 Park Avenue South, 3rd Floor, New York, NY (location) — Business address
FAQ
What is the primary business of Protara Therapeutics, Inc.?
Protara Therapeutics, Inc. is primarily involved in biological products, as indicated by its Standard Industrial Classification code [2836].
When was the company formerly known as ArTara Therapeutics, Inc.?
The company's name was changed from ArTara Therapeutics, Inc. on January 10, 2020.
What is the SEC file number for Protara Therapeutics, Inc.?
The Commission File Number for Protara Therapeutics, Inc. is 001-36694.
In which state was Protara Therapeutics, Inc. incorporated?
Protara Therapeutics, Inc. was incorporated in Delaware.
What is the fiscal year end for Protara Therapeutics, Inc.?
The fiscal year end for Protara Therapeutics, Inc. is December 31.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Protara Therapeutics, Inc. (TARA).